Revenue | ₹43.52Cr |
Net Profits | ₹2.15Cr |
Net Profit Margins | 4.94% |
Medicamen Biotech Ltd’s revenue fell -0.25% since last year same period to ₹43.52Cr in the Q1 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated 24.91% jump in its revenue since last 3-months.
Medicamen Biotech Ltd’s net profit jumped 59.26% since last year same period to ₹2.15Cr in the Q1 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated -10.42% fall in its net profits since last 3-months.
Medicamen Biotech Ltd’s net profit margin jumped 59.66% since last year same period to 4.94% in the Q1 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated -28.28% fall in its net profit margins since last 3-months.
The revenue for Medicamen Biotech Ltd in the Q1 results 2025 was ₹43.52Cr.
The net profit for Medicamen Biotech Ltd in the Q1 results 2025 was ₹2.15Cr.
The net profit margin for Medicamen Biotech Ltd in the Q1 results 2025 was 4.94%.
The revenue for Medicamen Biotech Ltd in the Q1 results 2024 was ₹43.63Cr.
The net profit for Medicamen Biotech Ltd in the Q1 results 2024 was ₹1.35Cr.
The net profit margin for Medicamen Biotech Ltd in the Q1 results 2024 was 3.09%.